Pfizer’s big fat fail 12/1/23
Pfizer shares sinking to March 2020 lows after the company halted its twice-daily weight loss pill. Just how big of a setback is this for the pharma heavyweight’s entry into the obesity drug race? The Fast Money traders debate. Fast Money Disclaimer
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Pfizer shares sinking to March 2020 lows after the company halted its twice-daily weight loss pill. Just how big of a setback is this for the pharma heavyweight’s entry into the obesity drug race? The Fast Money traders debate.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.